Challenge of Rechallenge: When to Resume Immunotherapy Following an Immune-Related Adverse Event

J Clin Oncol. 2019 Oct 20;37(30):2714-2718. doi: 10.1200/JCO.19.01623. Epub 2019 Aug 28.

Abstract

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Drug-Related Side Effects and Adverse Reactions / drug therapy*
  • Drug-Related Side Effects and Adverse Reactions / immunology*
  • Female
  • Humans
  • Immunotherapy / methods*
  • Male
  • Middle Aged